Oliver Lagore Vanvalin Investment Group’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.17K | Buy |
+50
| New | +$2.17K | ﹤0.01% | 548 |
|
|
2024
Q4 | $2.81K | Hold |
50
| – | – | ﹤0.01% | 554 |
|
|
2024
Q3 | $3.41K | Hold |
50
| – | – | ﹤0.01% | 535 |
|
|
2024
Q2 | $2.11K | Hold |
50
| – | – | ﹤0.01% | 595 |
|
|
2024
Q1 | $3.45K | Hold |
50
| – | – | ﹤0.01% | 558 |
|
|
2023
Q4 | $3.7K | Sell |
50
-26
| -34% | -$1.92K | ﹤0.01% | 558 |
|
|
2023
Q3 | $5.19K | Buy |
76
+26
| +52% | +$1.77K | ﹤0.01% | 536 |
|
|
2023
Q2 | $4.7K | Hold |
50
| – | – | ﹤0.01% | 572 |
|
|
2023
Q1 | $3.39K | Hold |
50
| – | – | ﹤0.01% | 535 |
|
|
2022
Q4 | $2.48K | Hold |
50
| – | – | ﹤0.01% | 537 |
|
|
2022
Q3 | $2K | Hold |
50
| – | – | ﹤0.01% | 520 |
|
|
2022
Q2 | $2K | Buy |
50
+25
| +100% | +$1K | ﹤0.01% | 492 |
|
|
2022
Q1 | $2K | Buy |
+25
| New | +$2K | ﹤0.01% | 498 |
|